Most Americans Favor Legalizing Marijuana for Medical, Recreational Use
Americans largely favor legalization of the drug, including 57% who say it should be legal for both medical and recreational use.
Americans largely favor legalization of the drug, including 57% who say it should be legal for both medical and recreational use.
Last year, Ozempic, Rybelsus and Wegovy had combined sales of about $21.1 billion globally – up 89% since 2022.
Just 20% of the public views the coronavirus as a major threat to the health of the U.S. population and only 10% are very concerned about getting a serious case themselves. In addition, a relatively small share of U.S. adults (28%) say they've received an updated COVID-19 vaccine since last fall.
About three-quarters of Americans say they have heard a lot or a little about Ozempic, Wegovy and other similar drugs that are being used for weight loss. Among those familiar with these drugs, 53% think they are good options to lose weight for people with obesity or a weight-related health condition.
More than half of U.S. adults (56%) said that widespread use of brain chips to enhance cognitive function would be a bad idea for society.
More Black Americans say health outcomes for Black people in the United States have improved over the past 20 years than say outcomes have worsened.
The share of Americans who say science has had a mostly positive impact on society has fallen 16 percentage points since before the start of the coronavirus outbreak, from 73% in January 2019 to 57% today.
Seven-in-ten Hispanic Americans say they’ve seen a doctor or other health care provider in the past year, compared with 82% among Americans overall.
Overall, there are about 42.5 million Americans with disabilities, making up 13% of the civilian noninstitutionalized population.
About nine-in-ten (88%) Americans say, overall, the benefits of childhood vaccines for measles, mumps and rubella outweigh the risks, identical to the share who said this before the coronavirus outbreak. U.S. adults are less confident in COVID-19 vaccines: Fewer than half rate them as having high health benefits and a low risk of side effects.